AU2002212494A1 - Method for detecting inhibitors of tumour growth - Google Patents

Method for detecting inhibitors of tumour growth

Info

Publication number
AU2002212494A1
AU2002212494A1 AU2002212494A AU1249402A AU2002212494A1 AU 2002212494 A1 AU2002212494 A1 AU 2002212494A1 AU 2002212494 A AU2002212494 A AU 2002212494A AU 1249402 A AU1249402 A AU 1249402A AU 2002212494 A1 AU2002212494 A1 AU 2002212494A1
Authority
AU
Australia
Prior art keywords
tumour growth
detecting inhibitors
inhibitors
detecting
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212494A
Inventor
Graciela Carrillo
Isabel Guerrero
Carlos Torroja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Publication of AU2002212494A1 publication Critical patent/AU2002212494A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002212494A 2000-11-02 2001-11-02 Method for detecting inhibitors of tumour growth Abandoned AU2002212494A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0026834.2 2000-11-02
GBGB0026834.2A GB0026834D0 (en) 2000-11-02 2000-11-02 Method for detecting inhibitors of tumour growth
PCT/GB2001/004891 WO2002036818A2 (en) 2000-11-02 2001-11-02 Method for detecting inhibitors of tumour growth

Publications (1)

Publication Number Publication Date
AU2002212494A1 true AU2002212494A1 (en) 2002-05-15

Family

ID=9902458

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212494A Abandoned AU2002212494A1 (en) 2000-11-02 2001-11-02 Method for detecting inhibitors of tumour growth

Country Status (3)

Country Link
AU (1) AU2002212494A1 (en)
GB (1) GB0026834D0 (en)
WO (1) WO2002036818A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044344A2 (en) * 2000-11-28 2002-06-06 Curis, Inc. Basal cell carcinoma cultures, methods related thereto and their use
WO2006080894A2 (en) * 2005-01-31 2006-08-03 Karolinska Institutet Innovations Ab Hedgehog inhibitor assay
ES2302625B1 (en) * 2006-09-30 2009-05-29 Consejo Sup. De Invest. Cientificas NON-HUMAN ANIMAL MODEL USEFUL FOR THE IDENTIFICATION OF PHARMACEUTICAL COMPOUNDS REGULATING THE VIA HEDGEHOG, PROCEDURE OF OBTAINING AND ITS USE IN A PROCEDURE OF IDENTIFICATION OF PHARMACEUTICAL COMPOUNDS REGULATING THE VIA HEDGEHOG.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780846B2 (en) * 1999-09-16 2005-04-21 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto

Also Published As

Publication number Publication date
WO2002036818A3 (en) 2003-10-02
WO2002036818A2 (en) 2002-05-10
GB0026834D0 (en) 2000-12-20

Similar Documents

Publication Publication Date Title
AU2002327422A1 (en) Method of identifying inhibitors of lck
AU2002316137A1 (en) Method of determining protein interaction inhibitors
AU3416200A (en) Method for determining the concentration of thrombin inhibitors
AU2002326949A1 (en) Method for the inhibition of methanogenesis
AU4256901A (en) Method of screening for inhibitors of osteopontin
AU2001236052A1 (en) Urease inhibitors
AUPR618401A0 (en) Method for determining soil salinity
AU3335400A (en) Method for determining properties of plant seeds
AU1036601A (en) Method of screening for inhibitors of asp1
AU2002353876A1 (en) System and method for depth profiling and characterization of thin films
AU2001252884A1 (en) Method of dopamine inhibition using l-threo-methylphenidate
AU2001287668A1 (en) Method for the sterilisation of objects
AU2001287268A1 (en) Method of identifying inhibitors of tie-2
AU5867901A (en) Method for detecting tumors
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2001270131A1 (en) Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring
AU2002212494A1 (en) Method for detecting inhibitors of tumour growth
AU2001227708A1 (en) Methods for identifying inhibitors of neuronal degeneration
AU4279900A (en) Method for determining plasminogen activator inhibitor
AU2003284140A1 (en) Method for inhibiting angiogenesis with ship-1 inhibitors
AU1073001A (en) Method of identifying inhibitors of cdc25
AU4021700A (en) Methods of use of beta1-integrin inhibitors
AU2001236440A1 (en) Method for the treatment of inflammation with spla2 inhibitors
AU2001246862A1 (en) Method of detecting cancer
AU5258701A (en) Method of searching for arteriosclerosis inhibitors and shrinkers